Premenstrual Complaints Before and After 40 Years of Age

Dear Editor
Premenstrual syndrome (PMS) may represent a continuum in a woman's reproductive life, but the mood and physical changes differ in presentation and severity from menarche to menopause (1, 2) . Daily self-rating forms that record symptom pattern and severity are commonly used to confirm the diagnosis of PMS or premenstrual dysphoric disorder (PMDD) (3) . Many studies have investigated the severity and chronological relation of symptoms to the menstrual cycle (4, 5) , but few studies have systematically looked at the impact of premenstrual symptoms in women as they approach perimenopause (2, (6) (7) (8) .
Although there is a definite overlap, it is expected that physical symptoms may be more dominant in women who are later in their reproductive years (8) . Thus, we conducted a pilot study, using self-rating scales to compare the severity of presenting symptoms and levels of distress in women with PMDD under age 40 years (n = 12) vs women age 40 years and over (n = 12). We used 3 questionnaires applied to premenstrual complaints: the Symptom Questionnaire (SQ) (9), the Sheehan Disability scale (SDS) (10), and the Self-Assessment of Symptoms Questionnaire (SAS). The SQ and SDS are validated scales. We based the SAS on mood and physical symptoms commonly reported during the menopausal transition.
Subjects diagnosed with PMDD gave written informed consent. They completed the questionnaires during the luteal phase (once only), and they reported menstrual history and general demographic data. We conducted independent t-tests to determine the effect of age on distress levels, as measured by the questionnaires.
Our preliminary findings indicate that there are no significant differences between the 2 groups in the mean total scores of distress levels and functional impairment. However, independent t-tests demonstrated a significant between-group difference (P < 0.05) on certain individual items: the group aged under 40 years reported more impairment in social life and leisure activities and more feelings of irritability. The group aged 40 years and over reported more frequent waking at night as well as more early waking. Nevertheless, these results should be viewed with caution because there were few participants, the questionnaires were only completed once, and the measures were not designed specifically for PMDD. The study also did not control for the use of selective serotonin reuptake inhibitors (SSRIs). Seven of the subjects over age 40 years reported current use of SSRIs for PMS, which may have influenced the ratings of mood symptoms. However, taking this into account, our results still indicate that the highest mean score in both groups was irritability, which supports the view that irritability is one of the dominant factors of PMDD (11, 12) .
Our preliminary findings suggest that specific mood and physical symptoms may change throughout the reproductive years, rather than as a whole across the overall clinical picture. Once the diagnosis of PMDD is made, emphasis on certain symptoms throughout the different phases of a woman's reproductive transition may assist in treatment recommendations.
We encourage a larger controlled study using standardized questionnaires to capture the premenstrual symptom profiles at various stages of the reproductive cycle. 
Norwalk Precipitates Severe Lithium Toxicity
Dear Editor:
Despite 50 years of medical experience with lithium, lithium toxicity remains a significant and primarily iatrogenic health problem (1) . The efficacy of lithium is marred by a narrow therapeutic index and significant potential toxicity (2) . Lithium toxicity can occur by overdose (intentional or accidental) or, more commonly, from alteration in its clearance by the kidneys. We present a case of lithium toxicity in an elderly patient subsequent to a "Norwalk virus-like" infection, wherein delay in making the correct diagnosis led to unnecessary suffering and prolonged hospitalization.
Case Report
The patient is a 75-year-old woman with a long history of bipolar illness and 
